WATSON 152 8 mg (Rapaflo 8 mg)

Generic Name: silodosin

Pill imprint WATSON 152 8 mg has been identified as Rapaflo 8 mg.

Rapaflo is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Rapaflo 8 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WATSON 152 8 mg (Rapaflo 8 mg)

Rapaflo 8 mg WATSON 152 8 mg
Rapaflo
Generic Name:
silodosin
Imprint:
WATSON 152
8 mg
Strength:
8 mg
Color:
White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
52544-0152

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web2)